Conditions:   Cushing's Disease,;   Acromegaly
Interventions:   Drug: Pasireotide s.c.;   Drug: Sitagliptin;   Drug: Liraglutide;   Drug: Insulin;   Drug: Pasireotide LAR;   Drug: Metformin
Sponsors:   Novartis;   Novartis Pharmaceuticals
Not yet recruiting - verified February 2014

Condition:   Symptomatic Dominant Liver Cyst
Interventions:   Drug: Pasireotide LAR 60 mg;   Procedure: Aspiration sclerotherapy;   Drug: Placebo
Sponsor:   Radboud University
Recruiting - verified January 2014

Conditions:   Primary Inoperable Thymoma;   Local Recurrent Thymoma
Intervention:   Drug: SOM230 LAR
Sponsors:   University of Regensburg;   Prof. Dr. Berthold Schalke;   Crolll Gmbh
Recruiting - verified December 2013

Condition:   Acromegaly
Intervention:   Drug: Pasireotide long acting release formulation
Sponsors:   Novartis;   Novartis Pharmaceuticals
Available - verified November 2013

Condition:   Cushing's Disease
Interventions:   Drug: Pasireotide;   Drug: Cabergoline
Sponsors:   Novartis;   Novartis Pharmaceuticals
Not yet recruiting - verified August 2013

Condition:   Neuroendocrine Carcinoma of the Lung and Thymus
Interventions:   Drug: Pasireotide LAR;   Drug: Everolimus;   Drug: Pasireotide LAR + Everolimus
Sponsors:   Novartis;   Novartis Pharmaceuticals
Not yet recruiting - verified August 2013

Condition:   Neuroendocrine Tumors
Intervention:   Drug: Pasireotide LAR
Sponsors:   Novartis;   Novartis Pharmaceuticals
Recruiting - verified July 2013

Condition:   Cancer
Intervention:   Drug: SOM230B
Sponsors:   University of Utah;   University of Utah;   Novartis
Terminated - verified July 2013

Condition:   Cushing's Disease
Intervention:   Drug: Pasireotide
Sponsors:   Novartis;   Novartis Pharmaceuticals
Completed - verified July 2013

Condition:   Cushing Disease
Intervention:   Drug: Pasireotide
Sponsors:   Novartis;   Novartis Pharmaceuticals
Completed - verified July 2013